While previous studies had connected changes in serine metabolism to NAFLD12,17, our findings offer mouse genetic evidence demonstrating the significance of SHMT2-mediated serine catabolism in the development of NAFLD. The gene discussed is SHMT2; the disease is metabolic dysfunction-associated steatotic liver disease.